Tech Company Financing Transactions
Catalyst Biosciences Funding Round
Private investors participated in a $13.4 million capital raise for Catalyst Biosciences. The round was recorded on 9/26/2012.
Transaction Overview
Company Name
Announced On
9/26/2012
Transaction Type
Venture Equity
Amount
$13,407,658
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
611 Gateway Blvd. 710
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nassim Usman
Chief Medical Officer
Howard Levy
VP - Bus. Development
Jeffrey Landau
VP - Operations
Andrew Hetherington
Browse more venture capital transactions:
Prev: 9/26/2012: Xeris Pharmaceuticals venture capital transaction
Next: 9/26/2012: Metaresolver venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs